Trials / Completed
CompletedNCT05336305
Polydextrose for Patients With Chronic Kidney Disease
Effects of Polydextrose Supplementation on Constipation in Patients Undergoing Hemodialysis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Universidade Federal Fluminense · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Constipation is a common complication in patients with chronic kidney disease (CKD), especially in hemodialysis (HD) patients. Reduced intake of fibre-rich food is among the most important causes of constipation. The study aims to investigate the possible influence of polydextrose (PDX) supplementation on constipation in patients with CKD on HD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Polydextrose | Administration of 3g polydextrose per day, for 2 months |
Timeline
- Start date
- 2021-03-30
- Primary completion
- 2021-05-30
- Completion
- 2021-10-30
- First posted
- 2022-04-20
- Last updated
- 2022-04-20
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05336305. Inclusion in this directory is not an endorsement.